Charles la Porte

Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects

Charles la Porte, Nha Voduc, Guijun Zhang et al. · Clinical Pharmacokinetics · 2010 · 259 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Interpatient variability in the pharmacokinetics of the HIV non‐nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and <i>CYP2B6</i> polymorphism

David M. Burger, Ilse van der Heiden, Charles la Porte et al. · British Journal of Clinical Pharmacology · 2005 · 211 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement

Salmaan Kanji, Meghan Hayes, Adam Ling et al. · Clinical Pharmacokinetics · 2015 · 172 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +9

Persistent HIV RNA shedding in semen despite effective antiretroviral therapy

Prameet M. Sheth, Colin Kovacs, Kimdar Sherefa Kemal et al. · AIDS · 2009 · 132 citations

Public Health, Infectious Diseases, Microbiology +17

Discordance in HIV‐1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma

Gianni R. Lorello, Charles la Porte, Richard Pilon et al. · HIV Medicine · 2009 · 63 citations

Public Health, Infectious Diseases, Pharmacology +17